Related content

Radiopharmaceutical therapy of bone metastases with ⁸⁹SrCl₂, ¹⁸⁶Re-HEDP and ¹⁵³Sm-EDTMP: a dosimetric study using Monte Carlo simulation

By Strigari L.   Sciuto R.   D’Andrea M.   Pasqualoni R.   Benassi M.   Maini C.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 7, 2007-07 ,pp. : 1031-1038

Springer Publishing Company

Access to resources Recommend Favorite

Rhabdomyosarcoma diffusely metastatic to the bone marrow: suspicious findings on ^99mTc-MDP bone scintigraphy confirmed by ¹⁸F-18 FDG PET/CT and bone marrow biopsy

By Iagaru Andrei   Goris Michael  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 9, 2008-09 ,pp. : 1746-1746

Springer Publishing Company

Access to resources Recommend Favorite

Prospective Evaluation of 99m Tc MDP Scintigraphy, 18 F NaF PET/CT, and 18 F FDG PET/CT for Detection of Skeletal Metastases

By Iagaru Andrei  

Molecular Imaging and Biology, Vol. 14, Iss. 2, 2012-04 ,pp. : 252-259

Springer Publishing Company

Access to resources Recommend Favorite

Clinical benefit of bone-targeted radiometabolic therapy with ¹⁵³Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer

By Ricci Sergio   Boni Giuseppe   Pastina Ilaria   Genovesi Dario   Cianci Claudia   Chiacchio Serena   Orlandini Cinzia   Grosso Mariano   AlSharif Abedallatif   Chioni Aldo   Donato Samantha   Francesca Francesco   Selli Cesare   Rubello Domenico   Mariani Giuliano  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 7, 2007-07 ,pp. : 1023-1030

Springer Publishing Company

Access to resources Recommend Favorite

^99mTc-depreotide scintigraphy of bone lesions in patients with lung cancer

By Mena Esther   Camacho Valle   Estorch Montserrat   Fuertes Jordi   Flotats Albert   Carrió Ignasi  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 10, 2004-10 ,pp. : 1399-1404

Springer Publishing Company

Access to resources Recommend Favorite